Assembly Biosciences (NASDAQ:ASMB) outlined its antiviral and liver disease development strategy during a fireside chat at ...
Assembly Biosciences (NASDAQ:ASMB) is awaiting a key development plan from partner Gilead Sciences for its herpes simplex ...
SHELTON, CT / ACCESS Newswire / June 8, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing antiviral drugs that viruses cannot escape, NanoViricides ...
Detailed price information for Assembly Biosciences (ASMB-Q) from The Globe and Mail including charting and trades.
Peer reviewed publication details pivotal data, demonstrating 30% improvement in disease-free survival (DFS) in patients with ...
However, there was a time when HIV and Aids was at its absolute peak. Between 2004 and 2005, this vicious disease claimed ...
Company plans to submit a Biologics License Application (BLA) for aglatimagene besadenovec (aglatimagene or CAN-2409) in localized, intermediate- ...
A cancer-killing virus has stopped pancreatic tumours from growing and spreading in three people in an initial safety trial, ...
Trogenix’s proprietary dual-payload AAV gene therapy; TGX-007 leverages Trogenix’s precision synthetic super-enha ...
Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on ...
Aerospace and Mechanical Insider on MSN
Why NASA sent two small orbiters to chase Mars’ vanishing air
How could a planet manage to lose its atmosphere that was sufficient for rivers and lakes to exist there? This is precisely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results